Skip to content

Effect of oral carbohydrate solution on safety and comfort of patients before painless digestive endoscopy

Clinical effect of preoperative oral carbohydrate on digestive endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078319
Enrollment
Unknown
Registered
2023-12-05
Start date
2023-12-05
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic disease

Interventions

200ml-pivot energy group:Oral administration of 200ml of Shuneng 2h before examination
400ml-pivot energy group:Oral administration of 400ml of Shuneng 2h before examination
200ml-drinking water group:Oral administration of 200ml of drinking water 2h before examination
400ml-drinking water group:Oral administration of 400ml of drinking water 2h before examination

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Patients who schedule to undergo painless gastroenteroscopy; (2)18-65 years old, regardless of gender; (3)ASA Class?-?; (4)BMI18-30 kg/m2; (5)Informed consent, voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Patients with severe heart, brain, lung, liver, kidney and metabolic diseases; (2)Patients with previous history of gastrointestinal surgery or gastrointestinal diversion surgery; (3)ECG showed that the heart rate was 180mmHg and/or diastolic blood pressure>110mmHg in patients with hypertension, or <90/60mmHg in patients with hypotension before examination; (5)Subjects have severe communication disorders caused by severe hearing deterioration; (6)Women during pregnancy, lactation and menstruation; (7)Diabetes with unstable blood sugar and diabetes related complications; (8)Patients with suspected gastroesophageal reflux disease, achalasia, severe eating and drinking disorders; (9)Recent use of drugs affecting gastric emptying; (10)Subjects who are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Gastric residual volume;

Secondary

MeasureTime frame
Perioperative blood glucose;Patient comfort (thirst, hunger, dry lips, nausea, vomiting, abdominal distension, abdominal pain, belching) ;Vital signs;Safety evaluation;

Countries

China

Contacts

Public ContactZhiping Wang

Affiliated Hospital of Xuzhou Medical University

zhpsqxt@126.com+86 133 3878 7071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026